2017 Program

Tuesday, July 11

 4:00 pm Arrival & Registration
 6:00 pm Biotech CEO Summit Welcome Reception
 6:30 pm

Opening Remarks and Participant Introductions

  • Sara Jane Demy, Founder & CEO, Demy-Colton & Advisory Board
 7:00 pm

Fireside Chat – The Purposeful CEO – Building a biotech that makes a difference 

  • Interviewee: Rich Heyman, Executive Chairman and Co-founder of Metacrine Inc. (Former CEO of Seragon & Aragon)
  • Interviewer: Mark Simon, Partner, Torreya Partners
  7:45 pm Networking Dinner Reception
10:00 pm Conclusion of Opening Events

Wednesday, July 12

7:00 am Breakfast
 8:15 am

Overview and Rules of Engagement

  • Sara Jane Demy, Founder & CEO, Demy-Colton
8:30 am

DISCUSSION 1: Setting the Strategic Direction—Are the Best Opportunities Aligned to Your “Reason for Being”

  • Ben Bonifant, Founder, Triangle Insights Group (Leader)
 9:45 am Morning Break
10:15 am

DISCUSSION 2: Strategic Direction and The Board—When and how do you engage them in strategic discussions?

  • Mark Kessel, Of Counsel, Shearman & Sterling LLP (Leader)
 11:15 am

DISCUSSION 3: Planning for approval and commercialization—Which steps are necessary and which are a waste of time and money?

  • Chris Apolito, Partner, Triangle Insights Group (Leader)
12:15 pm Networking Lunch on the patio
  1:15 pm

DISCUSSION 4: Maximizing returns – How do you balance your shareholder’s needs, patient access, perception of your company and perception of the industry?

  • Chris Ehrlich, Managing Director, Locust Walk (Leader)
 2:15 pm

DISCUSSION 5: Money – Which of the different flavors of capital for public and private companies is best for you? (Break out into two groups)

Private discussion:

  • Jennifer Friel Goldstein, Market Manager, Head of West Coast, Life Science & Healthcare and Accelerator, Silicon Valley Bank (Leader)

Public discussion:

  • KC Stone, Managing Director, BTIG, LLC (Leader)
 3:15 pm Afternoon Break
 3:30 pm  An unguarded conversation among CEOs & Friends – Embracing change

  • Interviewee: Cynthia Collins, CEO, Human Longevity, Inc.
  • Interviewer: Christos Richards, Partner, Catalyst Advisors, LP

Thursday, July 13

 7:00 am Breakfast
 8:00 am

DISCUSSION 6: Communications strategy– What is the right story for your company—and is the answer different depending on the audience?

  • Jeff Bergau, Founding Partner, CG Life (Leader)
 9:00 am

DISCUSSION 7: Leading through adversity; it happens to every biotech CEO—Whom should you consult for guidance, and how should you prioritize your response?

  • Ben Bonifant, Founder, Triangle Insights Group (Leader)
10:00 am Break
10:30 am

DISCUSSION 8: Team development—Does the company’s early team have the diversity of backgrounds and perspectives for later success?

  • Robin Toft, President & CEO, Toft Group Executive Search (Leader)
11:30 am

DISCUSSION 9: Board development—How do you prod your board toward adapting to new realities and get them in alignment with your vision?

  • Christos Richards, Partner, Catalyst Advisors, LP (Leader)
12:30 pm Lunch on the patio
 1:30 pm

DISCUSSION 10: Administrative change and the CEOs responsibilities—Policy changes can shake-up the landscape beyond imagination; when do you need to go beyond just staying informed?

  • Kathleen Sanzo, Partner, Morgan, Lewis & Bockius LLP (Leader)
 2:30 pm

DISCUSSION 11: Critical inflection points—How have you survived the make or break moments that led to success?

  • Jennifer Friel Goldstein, Market Manager, Head of West Coast, Life Science & Healthcare and Accelerator, Silicon Valley Bank, (Leader)
 3:30 pm

AN UNGUARDED CONVERSATION AMONG CEOS AND FRIENDS – The characteristics of a successful biotech CEO

  • Gaylene Xanthopoulos, President & Founder, The Leadership Edge (Leader)